Cadila Healthcare Limited has informed the Exchange regarding a press release dated July 02, 2021, titled "Zydus Cadila receives final approval from USFDA for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets".
Press Release Jul 02 2021
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jul 01 2021
- Press Release Jun 25 2021
- Press Release Jun 24 2021
- Press Release Jun 21 2021
- Press Release Jun 14 2021
Later from Zydus Lifesciences
- Press Release Jul 21 2021
- Press Release Jul 30 2021
- Press Release Aug 13 2021
- Press Release Aug 17 2021
- Press Release Aug 20 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences